View Author
patient limb perfusion perfusion melphalan response melanoma sarcoma tumour tissue necrosis factor cancer treatment toxicity extremity tumor oncol tumor necrosis factor eggermont disease study tumours survival month result tissue sarcoma tm-ilp amputation ann surg oncol tissue sarcomas tumour necrosis factor j clin oncol tnf-based metastase van geel stage effect grade progression response rates schraffordt koops h procedure response rate tnf-based ilp recurrence chapter therapy kroon bb signi combination lesion control surgery ann surg trial tumor necrosis factor-alpha experience prognostic table radiotherapy isolation perfusion in-transit leakage hagen tl factor-alpha chemotherapy melanoma in-transit metastases van tiel st report limb perfusions prognostic factors melanoma patients br j cancer resection lienard lejeune hyperthermic interferon gamma model analysis
5 Most Recent Publications
|
Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases
(Article)
Deroose, J.P. Grünhagen, D.J. Geel, A.N. van Wilt, J.H.W. de Eggermont, A.M.M. Verhoef, C. |
2011-11-01
|
|
Local excision of rectal cancer afterchemoradiation: Feasibility depends on the primary stage
(Article)
Burger, J.W.A. Graaf, E.J.R. de Doornebosch, P. Grünhagen, D.J. Biermann, K. Wilt, J.H.W. de Verhoef, C. |
2010-09-01
|
|
Isolated limb perfusion with TNF-α and melphalan in locally advanced soft tissue sarcomas of the extremities
(Article)
Eggermont, A.M.M. Grünhagen, D.J. Wilt, J.H.W. de Geel, A.N. van Verhoef, C. |
2009-08-21
|
|
Isolated limb perfusion with melphalan and TNF-α in the treatment of extremity sarcoma
(Article)
Verhoef, C. Wilt, J.H.W. Grünhagen, D.J. Geel, A.N. Hagen, T.L.M.T. Eggermont, A.M.M. |
2007-12-01
|
|
Clinical Utility of TNF-based Isolated Limb Perfusion to achieve Limb Salvage
(Doctoral Thesis)
Grünhagen, D.J. |
2006-03-29
|
